The SH2/SH3 domain-containing protein Nck is recognized by certain anti-phospholipase C-gamma 1 monoclonal antibodies, and its phosphorylation on tyrosine is stimulated by platelet-derived growth factor and epidermal growth factor treatment (Q24600605)
scientific article published on December 1, 1992
Language:
(P31) (Q13442814)
(P304) 5843-56
(P407) (Q1860)
(P433) 12
(P478) 12
(P577) +1992-12-00T00:00:00Z
(P921) (Q24771787)
(Q79460)
(Q242736)
(Q422248)
(P953) https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1448108/?tool=EBI
http://mcb.asm.org/cgi/content/abstract/12/12/5843
https://www.ncbi.nlm.nih.gov/pmc/articles/pmid/1448108/pdf/?tool=EBI
https://europepmc.org/articles/PMC360524
https://europepmc.org/articles/PMC360524?pdf=render
(P1433) (Q3319478)
(P1476) "The SH2/SH3 domain-containing protein Nck is recognized by certain anti-phospholipase C-gamma 1 monoclonal antibodies, and its phosphorylation on tyrosine is stimulated by platelet-derived growth factor and epidermal growth factor treatment" (language: en)
(P2093) J. Meisenhelder
T. Hunter
(P2860) (Q24616611)
(Q24310428)
(Q24600645)
(Q24600695)
(Q24337017)
(Q24336223)
(Q27860715)
(Q28131774)
(Q28307371)
(Q28242471)
(Q28186742)
(Q28625928)
(Q29620010)
(Q29618334)
(Q37577123)
(Q36208799)
(Q34166097)
(Q39585633)
(Q40820033)
(Q35103454)
(Q30195875)
(Q30195688)
(Q36688195)
(Q36807981)
(Q30441810)
(Q36441714)
(Q30195430)
(Q30195496)
(Q30195542)
(Q30195438)
(Q30195199)
(Q40083679)
(Q42817650)
(Q42808327)
(Q44049774)
(Q41737568)
(Q41684625)
(Q69041898)
(Q69078300)
(Q68352568)
other details
description scientific article published on December 1, 1992

External Links